In the span of less than 24 hours, two Trump administration nominees have suffered sudden blows—Trump’s pick to lead the Food and Drug Administration and his pick to lead the National Science Foundation.
Late Tuesday evening, Axios reported that the White House had abruptly withdrawn its controversial nomination of Heidi Overton to lead the FDA. Overton, a top conservative domestic policy aide in the White House, has drawn criticism and skepticism from Republicans and Democrats alike over her stances on vaccines, abortion, vapes, and birth control. Overton opposes abortion—though perhaps not strongly enough for some Republicans—and supported Trump and Kennedy’s decried anti-vaccine policies and statements, vexing Democrats.
In her confirmation hearing in September, Overton consistently stonewalled senators on every topic, refusing to directly answer even softball questions from friendly Republicans, leaving lawmakers on both sides of the aisle openly frustrated. The questions she dodged included those on how she would handle the FDA’s current safety review of the abortion pill, mifepristone, which extensive data has established is extremely safe. She also wouldn’t say whether she agreed with Trump when he falsely claimed the measles vaccine is “quite lethal” or that children are given vaccine doses the “size of a soda bottle.” Overton repeatedly refused to answer whether Trump could ever be wrong.
Axios quoted a senior Trump administration official as saying that Overton’s nomination was dropped because she “lacks the support on the Hill to move forward with her confirmation.”
The Senate’s Health, Education, Labor and Pensions (HELP) Committee, chaired by Bill Cassidy (R-La.), was scheduled to vote on Overton’s nomination Wednesday. In a social media post Tuesday night, after her nomination was withdrawn, Cassidy said he believed she had a “viable confirmation path.” But he said the nomination was “abandoned” after some anti-abortion senators sought commitments from her that they couldn’t get. “The Administration withdrew Dr. Overton rather than make such commitments,” Cassidy said.